Journal ID (nlm-ta): F1000Res
Journal ID (iso-abbrev): F1000Res
Journal ID (pmc): F1000Research
Title:
F1000Research
Publisher:
F1000Research
(London, UK
)
ISSN
(Electronic):
2046-1402
Publication date
(Electronic):
28
June
2017
Publication date Collection: 2017
Volume: 6
Electronic Location Identifier: F1000 Faculty Rev-1015
Affiliations
[1
]Department of Medicine, Division of Cardiology and Consortium for Fibrosis Research
& Translation, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA
[2
]Gladstone Institutes and Department of Medicine, Division of Cardiology, University
of California San Francisco School of Medicine, San Francisco, CA, USA
Author notes
Competing interests: MSS and TAM declare that they have no competing interests. SMH is a scientific founder
and shareholder of Tenava Therapeutics.
Author information
Article
DOI: 10.12688/f1000research.11339.1
PMC ID: 5497817
PubMed ID: 28721198
SO-VID: 1b89546a-a14e-44ac-a95b-6c563f23fa56
Copyright © Copyright: © 2017 Stratton MS et al.
License:
This is an open access article distributed under the terms of the Creative Commons
Attribution Licence, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited.
Funded by: National Institutes of Health
Award ID: HL116848
Funded by: National Institutes of Health
Award ID: HL127240
Funded by: National Institutes of Health
Award ID: 5T32HL007822
Funded by: National Institutes of Health
Award ID: F32HL126354
Funded by: American Heart Association
Award ID: 16SFRN31400013
Funded by: National Institutes of Health
Award ID: DK092821
TAM was supported by the National Institutes of Health (NIH) (HL116848 and HL127240)
and the American Heart Association (16SFRN31400013). SMH was funded by the NIH (HL127240
and DK093821). MSS was supported by a T32 training grant and an F32 fellowship from
the NIH (5T32HL007822 and F32HL126354).
The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript
.
Subject:
Review
Subject:
Articles
Subject:
Cell Signaling
Subject:
Control of Gene Expression
Subject:
Extrapulmonary Disorders & Therapeutic Interventions
Subject:
Gastrointestinal Pharmacology
Subject:
Immunopharmacology & Hematologic Pharmacology
Subject:
Interstitial Lung Diseases
Subject:
Liver Biology & Pathobiology
Subject:
Liver Failure & Liver Disease
Subject:
Nuclear Structure & Function
Subject:
Pathophysiology of Chronic Kidney Disease (CKD)
Subject:
Renal Immunology & Pathology (incl. Glomerular Diseases)
Subject:
Renal Pharmacology
Subject:
Respiratory Pharmacology